Trial · NCT07912502
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment Rate | Through completion of enrollment | Proportion of prescreened, eligible individuals who consent and enroll in the study, calculated as the number of participants who sign informed consent/assent divided by the number who pass prescreening. |
| Primary | Retention Rate | Baseline (Week 1) through Week 11 | Proportion of enrolled participants who complete the study through the Week 11 retention assessment. A pre-specified go/no-go benchmark of ≥85% retention was established. |
| Primary | Mindfulness Session Completion | Weeks 2 through 7 (6-week intervention period) | Percentage of prescribed Headspace mindfulness sessions (5 per week for 6 weeks; 30 total) completed per participant, captured via the Headspace API. A pre-specified go/no-go benchmark of ≥80% |
| Primary | Oura Ring Wear Adherence | Weeks 2 through 7 (6-week intervention period) | Percentage of intervention days with valid Oura Ring wear per participant. A pre-specified go/no-go benchmark of ≥80% of days was established. |
| Primary | Acceptability of Intervention Measure (AIM) Score | Week 7 (post-intervention) | Participant-rated acceptability of the Mind in Motion intervention, assessed using the 4-item Acceptability of Intervention Measure (scored 1-5; higher scores indicate greater acceptability). A pre-specified go/no-go benchmark of mean AIM ≥4.0 was established. |
| Secondary | Change in Injury-Related Fear (Tampa Scale of Kinesiophobia-11, TSK-11) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in TSK-11 total and subscale scores (range 11-44; higher scores indicate greater fear of movement/reinjury). A pre-specified go/no-go benchmark of ≥4-point change (published minimal detectable change) was established. |
| Secondary | Change in Psychological Readiness for Return to Activity (ACL-Return to Sport after Injury scale, ACL-RSI) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in ACL-RSI score (0-100 scale; higher scores indicate greater psychological readiness). |
| Secondary | Change in Reinjury Anxiety (Reinjury Anxiety Inventory, RIAI) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in RIAI score, assessing anxiety specifically related to reinjury. Scores range from 0 to 45 and higher scores reflect higher, more severe levels of re-injury anxiety. |
| Secondary | Change in Athletic Identity (Athletic Identity Measurement Scale, AIMS) | Baseline (Week 1) to post-intervention (Week 7) | Within-person change in AIMS score, assessing strength of identification with the athlete role. Scores range from 7 to 49 and higher scores indicate a stronger and more exclusive self-identification as an athlete. |
| Secondary | Change in Objectively Measured Moderate-to-Vigorous Physical Activity (MVPA) | Pre-intervention 7-day wear period (Week 1) compared to post-intervention 7-day wear period (Week 7) | Within-person change in daily MVPA (minutes/day) measured via a thigh-worn activPAL accelerometer over a 7-day wear period before and after the intervention. |
| Secondary | Within-Person Association Between Mindfulness Session Completion and Next-Day Anticipatory Fear | Weeks 2 through 7 (6-week intervention period) | Fixed-effects regression estimate testing whether days following a completed Headspace session are associated with lower next-day anticipatory fear of movement (assessed via twice-daily ecological momentary assessment), controlling for prior-day MVPA, time trend, and the daily activity-goal stimulus. |
| Secondary | Within-Person Association Between Mindfulness Session Completion and Next-Day MVPA | Weeks 2 through 7 (6-week intervention period) | Fixed-effects regression estimate testing whether days following a completed Headspace session are associated with higher next-day MVPA (assessed via Oura Ring), controlling for prior-day MVPA, time trend, and the daily activity-goal stimulus. |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07912502/registered